Pharmacologists are scientists who study how drugs interact with biological systems to understand their effects, mechanisms of action, and potential therapeutic uses. Their work involves evaluating how medications affect cells, tissues, and organs, both in healthy and diseased states. As the demand for more targeted and safer drugs grows, pharmacologists utilize advanced tools like molecular modeling, bioinformatics, and in vitro testing to enhance drug discovery processes. They also collaborate closely with toxicologists, clinicians, and pharmaceutical scientists to guide decision-making in drug development and regulatory approval. With growing emphasis on personalized medicine and biologics, pharmacologists are helping shape a future where treatments are more precisely tailored to individual patients. Their research continues to be foundational in understanding complex drug interactions and in the fight against diseases at the molecular level.
They also contribute significantly to pharmacovigilance by monitoring adverse drug reactions once therapies are in clinical use. In academic settings, pharmacologists are involved in educating future healthcare professionals and conducting cutting-edge research. Their knowledge supports the design of safer clinical trials and more effective treatment regimens. Pharmacologists play an essential role in translating lab discoveries into real-world therapies. As the pharmaceutical industry embraces innovation, the demand for skilled pharmacologists continues to rise globally.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia